Are you invested in CohBar, Inc.? If you own $CWBR shares, we would like to advise you that the Company is holding a Special Stockholders Meeting on October 4th, 2023, at 8 am ET. This meeting is being held to approve the proposed merger of CohBar and Morphogenesis. The proxy statement/prospectus related to the proposed merger is available here: https://bit.ly/44XonTp
About us
CohBar is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options.
- Website
-
http://www.cohbar.com
External link for CohBar, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Menlo Park, California
- Type
- Public Company
- Founded
- 2007
Locations
-
Primary
1455 Adams Drive
Menlo Park, California 94025, US